161 related articles for article (PubMed ID: 8313782)
1. Intraperitoneal chemotherapy for treatment and prevention of peritoneal carcinomatosis and sarcomatosis.
Sugarbaker PH
Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S115-22. PubMed ID: 8313782
[TBL] [Abstract][Full Text] [Related]
2. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
Baumgartner JM; Ahrendt SA; Pingpank JF; Holtzman MP; Ramalingam L; Jones HL; Zureikat AH; Zeh HJ; Bartlett DL; Choudry HA
J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis.
Bonvalot S; Cavalcanti A; Le Péchoux C; Terrier P; Vanel D; Blay JY; Le Cesne A; Elias D
Eur J Surg Oncol; 2005 Oct; 31(8):917-23. PubMed ID: 15975759
[TBL] [Abstract][Full Text] [Related]
5. Review of a personal experience in the management of carcinomatosis and sarcomatosis.
Sugarbaker PH
Jpn J Clin Oncol; 2001 Dec; 31(12):573-83. PubMed ID: 11902487
[TBL] [Abstract][Full Text] [Related]
6. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
7. Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
Begossi G; Gonzalez-Moreno S; Ortega-Perez G; Fon LJ; Sugarbaker PH
Eur J Surg Oncol; 2002 Feb; 28(1):80-7. PubMed ID: 11869020
[TBL] [Abstract][Full Text] [Related]
8. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
Sugarbaker PH; Jablonski KA
Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.
Salti GI; Ailabouni L; Undevia S
Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
[TBL] [Abstract][Full Text] [Related]
11. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
13. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Bijelic L; Yan TD; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2281-8. PubMed ID: 17503156
[TBL] [Abstract][Full Text] [Related]
14. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.
Rossi CR; Mocellin S; Pilati P; Foletto M; Quintieri L; Palatini P; Lise M
Surg Oncol Clin N Am; 2003 Jul; 12(3):781-94. PubMed ID: 14567031
[TBL] [Abstract][Full Text] [Related]
17. [Resectional treatment of peritoneal carcinomatosis followed by intraperitoneal chemotherapy, practical aspects].
Elias D; Lasser P; Reynard B; Ducreux M; Pocard M
J Chir (Paris); 2003 Oct; 140(5):270-6. PubMed ID: 14631291
[TBL] [Abstract][Full Text] [Related]
18. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
Vaira M; Robella M; Mellano A; Sottile A; De Simone M
Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
[TBL] [Abstract][Full Text] [Related]
19. [Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology].
Cavaliere F; Perri P; Rossi CR; Pilati PL; De Simone M; Vaira M; Deraco M; Di Filippo F
Tumori; 2003; 89(4 Suppl):21-3. PubMed ID: 12903536
[TBL] [Abstract][Full Text] [Related]
20. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
